Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Custom Media Event: ESG Summit
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Safety & Quality
March 30, 2015 01:00 AM

GNC to begin testing authenticity of its herbal supplements

Steven Ross Johnson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    GNC Holdings has reached a deal with New York State Attorney General Eric Schneiderman to implement new testing standards for its herbal supplements that will make it the first in the country to go beyond current federal requirements.

    The agreement (PDF) announced Monday will require the retailer to perform testing on all “active” plant ingredients listed on labels of its supplement products, as well as test for contamination with allergens before and after production. GNC will be required to implement the procedures for all its products at its more than 6,000 stores nationwide.

    “When consumers take an herbal supplement, they should be able to do so with full knowledge of what is in that product and confidence that every precaution was taken to ensure its authenticity and purity,” Schneiderman said in a statement released Monday. “When it comes to consumer health, we expect companies to reach a high safety bar. Without tests and safeguards, including those that rule out dangerous allergens, these supplements pose unacceptable risks to New York families. I urge all herbal supplements manufacturers and retailers to join GNC in working with my office to increase transparency and put the safety of their customers first.”

    The agreement comes in the wake of cease-and-desist notices Schneiderman's office sent to GNC, as well as fellow retail chains Target Corp., the Walgreen's holding company Walgreens Boots Alliance, and Wal-Mart Stores, in February for the sale of their store-brand supplements.

    The action was taken following an investigation that found that genetic material for the plants depicted on the labels for most of the products sold at those stores were not detected in the actual products. The study further detected DNA associated with plants not listed on the labels, as well as the presence of potential allergens.

    The attorney general found GNC supplements were produced in compliance with current regulations from the U.S. Food and Drug Administration, which raises questions as to whether federal standards were sufficient to ensure quality and safety of such products.

    FDA rules governing herbal supplements are not held to the same standards as prescription drugs and do not undergo the same type of rigorous testing requirements before being sold.

    Current FDA regulations do not mandate use of DNA-based technologies to authenticate supplement ingredients. Under the agreement, GNC will begin verifying the organic materials within its supplement using a technique called DNA bar coding over the next 18 months. The company will also conduct randomized testing for detection of the eight most common allergens—milk, eggs, peanuts, tree nuts, fish, shellfish, soy and wheat.

    GNC will provide semiannual reports on safety to the New York attorney general's office, and indicate in language used on store signs whether a supplement is derived from whole herbs or extracts, and explain the difference between those processes.

    In particular, such signs will highlight that extracts are chemicals derived from plants after applying solvents, such as liquid carbon dioxide. GNC will list all ingredients used in its products on its labels, per existing FDA rules.

    In response to the announcement, GNC released a statement saying the agreement reached affirmed their products were “not only safe and pure, but are in full compliance with all regulatory requirements,” CEO Michael Archbold said.

    “A robust testing regime, careful sourcing regimen and detailed manufacturing specifications have always been core elements to ensuring that we provide our customers with high-quality products,” Archbold said. “Our customers trust and value our products, and we are steadfastly committed to maintaining that trust and confidence—as an industry leader we have always gone above and beyond the minimum requirements in pursuing quality for our consumers, and we will continue to lead the efforts for higher standards.”

    It was not clear whether Target, Walgreen Co. and Wal-Mart would begin conducting similar testing of their supplements.

    The Council for Responsible Nutrition, a leading trade group for the dietary supplements manufacturing industry, blasted the deal.

    “The agreement announced today between the New York Attorney General and GNC performs a real disservice to consumers because it wrongly perpetuates the misdirected notion that DNA barcode testing is appropriate for herbal supplements, when it is not.,” said Steve Mister, CEO of CRN in a released statement. “Today's announcement substitutes reasoned judgment of scientists and federal experts with a politically-motivated mandate that does not advance the conversation around the quality of dietary supplements. “

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    coronavirus_covid-19_AP_edit_i.jpg
    Dominant coronavirus mutant contains ghost of pandemic past
    Pandemic-weary Americans plan for summer despite COVID surge
    Pandemic-weary Americans plan for summer despite COVID surge
    Sponsored Content
    COVID-19 Coverage Newsletter: Sign up today to receive a comprehensive daily newsletter designed for healthcare leaders looking for the most accurate and comprehensive resources related to coronavirus.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
      • Custom Media Event: ESG Summit
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing